Penumbra, Inc. (PEN)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 12:10PM EDT. Market open.
| Previous close | 201.84 |
| Open | 202.70 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's range | 200.51 - 204.04 |
| 52-week range | 180.93 - 348.67 |
| Volume | |
| Avg. volume | 337,204 |
| Market cap | 7.857B |
| Beta (5Y monthly) | 0.53 |
| PE ratio (TTM) | 87.50 |
| EPS (TTM) | 2.32 |
| Earnings date | 07 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 277.38 |
PR NewswirePenumbra, Inc. Schedules First Quarter 2024 Earnings Release and Conference Call for May 7, 2024
Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2024 after market close on Tuesday, May 7, 2024 at 4:30 PM Eastern Time. A press release with first quarter 2024 financial results will be issued after market close that day.
ZacksHere's Why You Should Retain Penumbra (PEN) Stock for Now
Investors are optimistic about Penumbra (PEN) on strength exhibited in the Thrombectomy business and global expansion.
GuruFocus.comInsider Sell: EVP, General Counsel & Secretary Johanna Roberts Sells Shares of Penumbra Inc ...
Penumbra Inc (NYSE:PEN), a global healthcare company focused on innovative therapies, has seen a recent insider transaction according to the latest SEC filings.
© 2024 Yahoo. All rights reserved.